marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-10-2022
PLx Pharma Financial Statements 2011-2024 | PLXP
Annual Financial Statements PLx Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
118 M | 49.3 M | 51.6 M | 47 M | 45.6 M | 15 M | 76.3 M | 86.4 M | - | - | - |
Shares |
23.7 M | 9.16 M | 8.92 M | 8.73 M | 7.02 M | 1.3 M | 1.18 M | 981 K | - | - | - |
Historical Prices |
5.05 | 7.43 | 5.68 | 4.85 | 6.4 | 8.8 | 60 | 114 | - | - | - |
Net Income |
-46.1 M | -15.2 M | -20.5 M | 896 K | -15.3 M | -21.3 M | -18.7 M | -13.6 M | -4.01 M | -1.84 M | - |
Revenue |
8.21 M | 30.4 K | 565 K | 753 K | 779 K | - | - | - | - | - | - |
Cost of Revenue |
4.8 M | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
3.4 M | 30.4 | - | - | - | - | - | - | - | - | - |
Operating Income |
-40.8 M | -13.5 M | -14.2 M | -11 M | -15.8 M | -4.81 M | -18.8 M | -13.6 M | -4.01 M | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-40.7 M | -13 M | -14 M | -10.8 M | -13.4 M | -21.4 M | -18.8 M | -13.6 M | -4.01 M | -1.84 M | - |
Operating Expenses |
44.2 M | 13.5 M | 14.8 M | 11.7 M | 14.3 M | 21.4 M | 18.8 M | 13.6 M | - | - | - |
General and Administrative Expenses |
40 M | 9.15 M | 10 M | 7.79 M | 10.2 M | 8.61 M | 7.48 M | 4.68 M | 2.28 M | 999 K | - |
All numbers in USD currency
Quarterly Income Statement PLx Pharma
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 28.6 M | 27.7 M | 27.5 M | 27.5 M | 26.9 M | 23.6 M | 16.4 M | 13.9 M | 9.16 M | 9.16 M | 9.16 M | 9.16 M | 8.92 M | 8.78 M | 8.75 M | 8.74 M | 8.74 M | 8.73 M | 8.73 M | 8.72 M | 8.7 M | 6.16 M | 4.38 M | 4.38 M | 4.38 M | 4.38 M | 10.3 M | 10.3 M | 10.3 M | 8.58 M | 8.55 M | 8.54 M | 8.54 M | 8.54 M | 5.75 M | - | 4.77 M | 4.43 M | 4.37 M | - | - | - | - | - | - | - | - |
Net Income |
- | -8.5 M | -11.9 M | -10.8 M | - | -21.6 M | -16.5 M | -11.5 M | - | -3.13 M | -5.6 M | 1.5 M | - | 1.7 M | -9.35 M | -10.9 M | - | -3.43 M | -3.6 M | 4.98 M | - | -3.8 M | -2.24 M | -1.43 M | - | -1.08 M | -1.47 M | -5.82 M | - | -5.02 M | -4.03 M | -4.19 M | - | -3.84 M | -3.92 M | -2.54 M | - | -991 K | -363 K | -4.01 M | - | - | - | - | - | - | - | - |
Revenue |
- | 386 K | 483 K | 2.08 M | - | 6.62 M | - | - | - | - | 27.9 K | 2.52 K | - | 41.1 K | 183 K | 318 K | - | 217 K | 167 K | 81.5 K | - | 62.3 K | 376 K | - | - | 20 K | 20 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | 1.46 M | 820 K | 1.17 M | - | 3.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | -1.07 M | -337 K | 914 K | - | 2.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -10.8 M | -14.5 M | -18.2 M | - | -9.86 M | -6.48 M | -3.6 M | - | -3.19 M | -3.57 M | -3 M | - | -3.68 M | -3.85 M | -2.92 M | - | -2.8 M | -2.4 M | -3.24 M | - | -3.92 M | -4.28 M | -1.35 M | - | -1.05 M | -1.44 M | -5.83 M | - | -5.03 M | -4.03 M | -4.19 M | - | -3.84 M | -3.92 M | -2.54 M | - | -991 K | -363 K | -407 K | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -10.7 M | -14.5 M | -18.2 M | - | -9.78 M | -6.42 M | -3.57 M | - | -3.09 M | -3.51 M | -2.97 M | - | -3.55 M | -3.75 M | -2.86 M | - | -2.66 M | -2.31 M | -3.2 M | - | -3.91 M | -4.27 M | -1.35 M | - | -1.05 M | -1.44 M | -5.83 M | - | -5.03 M | -4.03 M | -4.19 M | - | -3.84 M | -3.92 M | -2.54 M | - | -991 K | -363 K | -407 K | - | - | - | - | - | - | - | - |
Operating Expenses |
- | 9.76 M | 14.2 M | 19.1 M | - | 12.6 M | 6.48 M | 3.6 M | - | 3.19 M | 3.6 M | 3.01 M | - | 3.72 M | 4.03 M | 3.24 M | - | 3.02 M | 2.56 M | 3.32 M | - | 3.98 M | 4.65 M | 1.35 M | - | 1.05 M | 1.46 M | 5.83 M | - | 5.03 M | 4.03 M | 4.19 M | - | 3.84 M | 3.92 M | 2.54 M | - | 991 K | 363 K | 407 K | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | 9.14 M | 13.6 M | 18.5 M | - | 11 M | 5.5 M | 2.64 M | - | 1.98 M | 2.21 M | 2.49 M | - | 2.5 M | 2.43 M | 2.24 M | - | 1.8 M | 1.83 M | 2.24 M | - | 3.02 M | 4.02 M | 1.22 M | - | 1.04 M | 1.45 M | 2.25 M | - | 1.57 M | 1.74 M | 2.48 M | - | 1.31 M | 1.33 M | 727 K | - | 355 K | 329 K | 284 K | - | - | - | - | - | - | - | - |
All numbers in USD currency